-
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients With CancerKhorana AA, Soff GA, CASSINI Investigators. -
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJ Herrmann, D Lenihan, S Armenian et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
